Pharmafile Logo
Pharmafocus logo
Advanced Search

First generic challenger to Paxil hits US market

October 28, 2003

News

Novartis Cox-II contender approved in UK

October 28, 2003

A new rival to blockbuster Cox-II inhibitor drugs from Pfizer and Merck Sharp & Dohme has been approved in the …

News

Push for greater data transparency, NICE told

October 28, 2003

News

Restructure unveiled as Pfizer takes merger hit

October 28, 2003

Pfizer has unveiled a restructuring of its business to maximise its R&D and marketing might following the acquisition of Pharmacia …

News

New company to capitalise on industry M&A activity

October 28, 2003

A new private European pharma company has been launched that will exploit products made available through the spate of industry …

News

AstraZeneca targets Canadian parallel imports

October 28, 2003

AstraZeneca has become the second major pharma company to limit sales of drugs to Canada in a bid to curb …

News

New guidelines for industry ‘disease awareness’ campaigns

October 28, 2003

Pharmaceutical industry 'disease awareness campaigns' aimed at UK consumers are to be governed by new guidelines to formalise the practice …

News

GSK’s NiQuitin in pole position with Formula One

October 28, 2003

News

New guidance for nurse and GP specialists

October 28, 2003

New guidance has been issued to help nurses and GPs take on extra roles that will expand primary care services.The …

News

Scientists race to identify and treat SARS

October 28, 2003

Pharmaceutical companies, researchers and academic virologists around the world have joined the race to identify and ultimately develop vaccines to …

News

Income guarantee to salvage new GP contract

October 28, 2003

Plans to offer GP practices a guaranteed minimum income have been launched to rescue the new general practice contract.The proposals …

News

UK consolidation underway as British Biotech merges

October 28, 2003

News

$180bn Pfizer moves into a league of its own

October 28, 2003

$180bn Pfizer moves into a league of its ownThe newly enlarged Pfizer has begun life bullishly with a 10% growth …

News

Companies pay $344m fraud settlement

October 28, 2003

GlaxoSmithKline and Bayer have agreed to pay $344 million to settle charges of defrauding the US Government healthcare system.The payout …

News

Health service to pilot US system to tackle admissions

October 28, 2003

Primary care trusts in England are to work with US healthcare provider Kaiser Permanente on new ways to reduce hospital …

News

Abbott looks to seize lion’s share of RA market with Humira

October 28, 2003

Abbott Laboratories has launched its new rheumatoid arthritis treatment Humira in Europe claiming its biggest ever product could eventually become …

News

Novartis’ Cox-II challenger suffers set back

October 28, 2003

Prexige, the new challenger to the established Cox-II drugs from Novartis has been dealt a serious blow after the FDA …

News

Hassan takes on Schering-Plough revival

October 28, 2003

Fred Hassan has outlined his plans to turn round the fortunes of struggling Schering-Plough after being installed as the company's …

News

Swiss franc undercuts Roche growth

October 28, 2003

Sales revenues at Roche have been dealt a serious blow by currency fluctuations in the first quarter, with a strong …

News

Ageing atypical could help cut suicide levels

October 28, 2003

Novartis' atypical antipsychotic Clozaril could lead to a reduction in suicide rate among patients suffering from schizophrenia, according to a …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026